ID

40403

Description

First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00927927

Link

https://clinicaltrials.gov/show/NCT00927927

Keywords

Versions (1)
  1. 4/18/20 4/18/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

April 18, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Inflammation NCT00927927

English

Eligibility Inflammation NCT00927927

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
active rheumatoid arthritis, characterized by a disease activity score (das28) above 3.2, and a diagnosis of at least three months duration
Description

Rheumatoid Arthritis Duration Disease activity score das28

Data type

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C4481729
aged between 18 and 75 years (both inclusive)
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
subjects on stable doses of methotrexate for at least 4 weeks prior to dosing
Description

Methotrexate Dose Stable

Data type

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
use of highly effective contraception during the trial (both males and females)
Description

Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
a chronic inflammatory autoimmune or joint disease other than ra (rheumatoid arthritis)
Description

Autoimmune Diseases inflammatory chronic | Inflammatory joint disease chronic | Exception Rheumatoid Arthritis

Data type

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C0333348
UMLS CUI [1,3]
C0205191
UMLS CUI [2,1]
C0683381
UMLS CUI [2,2]
C0205191
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0003873
an active or latent tuberculosis
Description

Tuberculosis | Latent Tuberculosis

Data type

boolean

Alias
UMLS CUI [1]
C0041296
UMLS CUI [2]
C1609538
any investigational or experimental therapy within 4 weeks or 5 half-lives (whichever is longer) prior to the screening visit
Description

Therapies, Investigational

Data type

boolean

Alias
UMLS CUI [1]
C0949266
a known significant cardio-vascular disease
Description

Cardiovascular Disease

Data type

boolean

Alias
UMLS CUI [1]
C0007222
vaccination against live virus or bacteria within 4 weeks prior to randomization
Description

Vaccination Against Virus | Vaccination Against Bacteria

Data type

boolean

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C0521124
UMLS CUI [1,3]
C0042776
UMLS CUI [2,1]
C0042196
UMLS CUI [2,2]
C0521124
UMLS CUI [2,3]
C0004611
the use of concomitant medications that are prohibited in the trial (e.g., certain dmards (antirheumatic therapies that are disease modifying), biologics (here: biotechnologically produced antibodies), intra-articular corticoid-injections, etc.)
Description

Pharmaceutical Preparations Illicit | DMARDs Some | Biological agents Some | Corticoid Intra-Articular Injections

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332266
UMLS CUI [2,1]
C0242708
UMLS CUI [2,2]
C0205392
UMLS CUI [3,1]
C0005515
UMLS CUI [3,2]
C0205392
UMLS CUI [4,1]
C0001617
UMLS CUI [4,2]
C0021488
a positive test result for human immunodeficiency virus (hiv) infection, hepatitis b and/or hepatitis c, or tuberculosis skin test
Description

Positive Test Result HIV Infection | Hepatitis B positive | Hepatitis C positive | Tuberculosis skin test Positive

Data type

boolean

Alias
UMLS CUI [1,1]
C1335447
UMLS CUI [1,2]
C0019693
UMLS CUI [2]
C0856706
UMLS CUI [3]
C1112419
UMLS CUI [4,1]
C0041290
UMLS CUI [4,2]
C1514241
donation of greater than or equal to 400 ml of blood within 8 weeks prior to trial entry
Description

Blood Donation Amount Timespan

Data type

boolean

Alias
UMLS CUI [1,1]
C0005794
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0872291
Back to the top of the page

Similar models

Eligibility Inflammation NCT00927927

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Rheumatoid Arthritis Duration Disease activity score das28
Item
active rheumatoid arthritis, characterized by a disease activity score (das28) above 3.2, and a diagnosis of at least three months duration
boolean
C0003873 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C4481729 (UMLS CUI [1,3])
Age
Item
aged between 18 and 75 years (both inclusive)
boolean
C0001779 (UMLS CUI [1])
Methotrexate Dose Stable
Item
subjects on stable doses of methotrexate for at least 4 weeks prior to dosing
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Contraceptive methods
Item
use of highly effective contraception during the trial (both males and females)
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Autoimmune Diseases inflammatory chronic | Inflammatory joint disease chronic | Exception Rheumatoid Arthritis
Item
a chronic inflammatory autoimmune or joint disease other than ra (rheumatoid arthritis)
boolean
C0004364 (UMLS CUI [1,1])
C0333348 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0683381 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0003873 (UMLS CUI [3,2])
Tuberculosis | Latent Tuberculosis
Item
an active or latent tuberculosis
boolean
C0041296 (UMLS CUI [1])
C1609538 (UMLS CUI [2])
Therapies, Investigational
Item
any investigational or experimental therapy within 4 weeks or 5 half-lives (whichever is longer) prior to the screening visit
boolean
C0949266 (UMLS CUI [1])
Cardiovascular Disease
Item
a known significant cardio-vascular disease
boolean
C0007222 (UMLS CUI [1])
Vaccination Against Virus | Vaccination Against Bacteria
Item
vaccination against live virus or bacteria within 4 weeks prior to randomization
boolean
C0042196 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0042776 (UMLS CUI [1,3])
C0042196 (UMLS CUI [2,1])
C0521124 (UMLS CUI [2,2])
C0004611 (UMLS CUI [2,3])
Pharmaceutical Preparations Illicit | DMARDs Some | Biological agents Some | Corticoid Intra-Articular Injections
Item
the use of concomitant medications that are prohibited in the trial (e.g., certain dmards (antirheumatic therapies that are disease modifying), biologics (here: biotechnologically produced antibodies), intra-articular corticoid-injections, etc.)
boolean
C0013227 (UMLS CUI [1,1])
C0332266 (UMLS CUI [1,2])
C0242708 (UMLS CUI [2,1])
C0205392 (UMLS CUI [2,2])
C0005515 (UMLS CUI [3,1])
C0205392 (UMLS CUI [3,2])
C0001617 (UMLS CUI [4,1])
C0021488 (UMLS CUI [4,2])
Positive Test Result HIV Infection | Hepatitis B positive | Hepatitis C positive | Tuberculosis skin test Positive
Item
a positive test result for human immunodeficiency virus (hiv) infection, hepatitis b and/or hepatitis c, or tuberculosis skin test
boolean
C1335447 (UMLS CUI [1,1])
C0019693 (UMLS CUI [1,2])
C0856706 (UMLS CUI [2])
C1112419 (UMLS CUI [3])
C0041290 (UMLS CUI [4,1])
C1514241 (UMLS CUI [4,2])
Blood Donation Amount Timespan
Item
donation of greater than or equal to 400 ml of blood within 8 weeks prior to trial entry
boolean
C0005794 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0872291 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial